NCT05384067

Brief Summary

The purpose of Project MiCRIM is to test the feasibility and effectiveness of an online 4-week mindfulness-based intervention that incorporates informational elements about sleep, mindfulness, thoughts, emotions, and acceptance using a control sample of Criminology and Criminal Justice majors as a proxy for Corrections officers.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
31

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started May 2022

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2022

Completed
11 days until next milestone

First Submitted

Initial submission to the registry

May 12, 2022

Completed
8 days until next milestone

First Posted

Study publicly available on registry

May 20, 2022

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 31, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 31, 2023

Completed
Last Updated

July 27, 2023

Status Verified

July 1, 2023

Enrollment Period

11 months

First QC Date

May 12, 2022

Last Update Submit

July 24, 2023

Conditions

Keywords

mindfulnesssleepstress

Outcome Measures

Primary Outcomes (6)

  • Saliva Samples via ELISA Assay- Cortisol

    Tests for level changes in cortisol.

    Change from baseline to 5 weeks

  • Saliva Samples via ELISA Assay- α-amylase

    Test for level changes in α-amylase.

    Change from baseline to 5 weeks

  • Saliva Samples via ELISA Assay- interleukin-1beta

    Test for level changes in interleukin-1beta.

    Change from baseline to 5 weeks

  • Saliva Samples via ELISA Assay- interleukin-6

    Test for level changes in interleukin-6.

    Change from baseline to 5 weeks

  • Saliva Samples via ELISA Assay- interleukin-8

    Test for level changes in interleukin-8.

    Change from baseline to 5 weeks

  • Saliva Samples via ELISA Assay- TNF-α

    Test for level changes in TNF-α.

    Change from baseline to 5 weeks

Secondary Outcomes (9)

  • Pittsburgh Sleep Quality Index (PSQI)

    Change from baseline to 5 weeks

  • Pittsburgh Sleep Quality Index, Addendum for PTSD (PSQI-A)

    Change from baseline to 5 weeks

  • The Smith Relaxation Dispositions Inventory

    Change from baseline to 5 weeks

  • Five Facet Mindfulness Questionnaire - Short Form

    Change from baseline to 5 weeks

  • Patient Health Questionnaire 9

    Change from baseline to 5 weeks

  • +4 more secondary outcomes

Study Arms (2)

Mindfulness-based intervention

EXPERIMENTAL

Participants in this arm will wear a sleep-monitoring device, complete questionnaires and participate in an online mindfulness component each week for the duration of this study.

Behavioral: Mindfulness-based intervention

Control

NO INTERVENTION

Participants in this arm will only wear a sleep-monitoring device and complete questionnaires.

Interventions

Participants will complete one mindfulness education module every week for 4 weeks, and to practice a 15-minute formal guided mindfulness meditation at least five times per week across the 4 weeks. Participants will also be taught evidence-based sleep improvement techniques, will be provided education for when to use the techniques, and will be encouraged to implement the techniques to improve sleep.

Mindfulness-based intervention

Eligibility Criteria

Age18 Years - 24 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Criminal Justice or Criminology major

You may not qualify if:

  • Abnormal BMI (below 18.5 or above 30)
  • self-reported sleep apnea, head injury, neurological problem, unstable mental health disorder, substance use disorder, psychosis, or current suicidal ideation or plan

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Florida State University Center for Translational Behavioral Medicine

Tallahassee, Florida, 32310, United States

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Intervention and control group
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

May 12, 2022

First Posted

May 20, 2022

Study Start

May 1, 2022

Primary Completion

March 31, 2023

Study Completion

March 31, 2023

Last Updated

July 27, 2023

Record last verified: 2023-07

Locations